The circulating CD4+CXCR5+FOXP3+ Tfrs with enhanced suppressive function could alleviate autoimmunity in RA patients by reducing IgG and IgM levels, and the proportion of Tfrs was negatively correlated with the disease severity. The gene discussed is CXCR5; the disease is rheumatoid arthritis.